MarketInOut Stock Screener Log In | Sign Up

Rebus Holdings Ltd

OTC • Healthcare • Biotechnology • Quote as of 11/03/2026
Rebus Holdings Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.003213 mln
Float31.27 mln

EPS

0.04
Marginal

P / E

0.00
Anomalous

Relative Strength

58 / 100
Slightly ahead

ROE

19.88
Healthy

ROA

-216
Deeply negative

Business Description

Rebus Holdings Inc. is a California-based company founded in 2003 that develops targeted cancer treatments. Its primary drug candidate, RT-AR001, works by blocking adenosine receptors and is injected directly into tumors to improve patient outcomes.

Key Fundamentals

EPS0.04
P/E0.00
ROE19.88
ROIC13.48
ROA-216
Interest Cover-9.62
EBITDA, mln1.07
EV / EBITDA-0.34

Quote Details

Last 0.000001
Change -0.000099 (-99%)
Open 0.0001
Volume 195,539
Turnover 0.1955
Average Volume 16,174

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 56 / 100   
1 Month -99% 0 / 100   
2 Months -99% 0 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog